COVID-19 Briefing Series: Launch in the Age of COVID-19

Home / Intelligence / Briefs / COVID-19 Briefing Series: Launch in the Age of COVID-19

While COVID-19 is grinding world economies to a potentially disastrous halt, the pharmaceutical and biotech industry continues to move forward at a slower pace.

How can companies ensure an agile launch despite the uncertainty and ensure launch success during and in a post-COVID-19 world?

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit

For more information:

Elizabeth Marshall
Trinity Life Sciences

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.